Publications by authors named "Rikki Arai"
Purpose: The purpose of this study was to investigate the bacterial composition in the conjunctiva and to determine the relationship between fluoroquinolone resistance and mutations in the quinolone resistance-determining region (QRDR) in Corynebacterium macginleyi (C. macginleyi).
Methods: Bacteria isolated from conjunctival swabs of patients awaiting ophthalmic surgery or patients with presumed keratoconjunctivitis were included in this study.
Purpose: To explore the clinical features of COVID-19-associated conjunctivitis with the objective of preventing the spread of infection.
Study Design: Retrospective cohort study.
Methods: From March 2020 to March 2021, we retrospectively reviewed 26 (9.
Article Synopsis
- This study examines the effects of intravitreal injections of two anti-VEGF agents, brolucizumab and aflibercept, on ocular blood flow in patients with neovascular age-related macular degeneration (nAMD).
- The research included 21 eyes of Japanese patients and measured blood flow rates at the optic nerve head and choroid before and after injections, using laser speckle flowgraphy.
- Both treatment groups showed significant decreases in ocular blood flow after injection, with no major differences between the two agents; however, a notable percentage of eyes treated with brolucizumab experienced a greater decrease in choroidal blood flow compared to those treated with aflibercept.
Purpose: Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents reduces microaneurysms in patients with diabetic macular edema (DME). However, residual anti-VEGF-resistant telangiectatic capillaries (TelCaps) have been reported. In this study, we investigated changes in the size of TelCaps after intravitreal injection of anti-VEGF agents in DME.
View Article and Find Full Text PDF